Medical Communications

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …

NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …

The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …

Pharmacists in England have warned that they are struggling to obtain many common generic medicines, as the number of medicines …

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …